Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · IEX Real-Time Price · USD
30.15
+1.05 (3.61%)
At close: Jul 19, 2024, 4:00 PM
30.02
-0.13 (-0.43%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Sanara MedTech Market Cap
Sanara MedTech has a market cap or net worth of $260.05 million as of July 22, 2024. Its market cap has decreased by -19.09% in one year.
Market Cap
260.05M
Enterprise Value
268.92M
1-Year Change
-19.09%
Ranking
Category
Stock Price
$30.15
Market Cap Chart
Since December 1, 1998, Sanara MedTech's market cap has increased from $5.50M to $260.05M, an increase of 4,628.18%. That is a compound annual growth rate of 16.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 260.00M | -25.90% |
| Dec 29, 2023 | 350.90M | -7.12% |
| Dec 30, 2022 | 377.80M | 67.54% |
| Dec 31, 2021 | 225.50M | -28.21% |
| Dec 31, 2020 | 314.10M | 446.26% |
| Dec 31, 2019 | 57.50M | 687.67% |
| Dec 31, 2018 | 7.30M | 8.96% |
| Dec 29, 2017 | 6.70M | 52.27% |
| Dec 30, 2016 | 4.40M | -54.64% |
| Dec 31, 2015 | 9.70M | 83.02% |
| Dec 31, 2014 | 5.30M | -43.62% |
| Dec 31, 2013 | 9.40M | 261.54% |
| Dec 31, 2012 | 2.60M | -88.79% |
| Dec 30, 2011 | 23.20M | 53.64% |
| Dec 31, 2010 | 15.10M | -79.17% |
| Dec 31, 2009 | 72.50M | -16.38% |
| Dec 31, 2008 | 86.70M | 431.90% |
| Dec 31, 2007 | 16.30M | 1,937.50% |
| Dec 29, 2006 | 800.00K | -66.67% |
| Dec 30, 2005 | 2.40M | -86.67% |
| Dec 31, 2004 | 18.00M | 8,900.00% |
| Dec 31, 2003 | 200.00K | - |
| Dec 31, 2002 | - | -100.00% |
| Dec 31, 2001 | 3.70M | -64.42% |
| Dec 29, 2000 | 10.40M | 642.86% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenaya Therapeutics | 266.17M |
| Viemed Healthcare | 264.37M |
| Zentalis Pharmaceuticals | 262.75M |
| Inovio Pharmaceuticals | 260.92M |
| Monte Rosa Therapeutics | 260.50M |
| MultiPlan | 257.95M |
| Nektar Therapeutics | 255.79M |
| CorMedix | 255.56M |